Colchicine in athero-thrombosis: molecular mechanisms and clinical evidence

HIGHLIGHTS

  • who: Giovanni Cimmino and colleagues from the Department of Translational Medical Sciences, Section of Cardiology, University of Campania Luigi Vanvitelli, Naples, Italy have published the Article: Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence, in the Journal: (JOURNAL)
  • what: This study showed that adding low dose (0.5 mg/day) colchicine to the optimal medical treatment significantly reduced the risk of acute coronary events, out-of-hospital cardiac arrests, and non cardioembolic ischemic strokes . This study failed in demonstrating benefits derived by colchicine treatment since no differences were demonstrated between groups in terms of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?